Methyl 3,6-dihydro-2H-pyran-4-carboxylate, 95.0%, 1g

2-Chloro-N-pyridin-4-ylmethyl-acetamide, 250mg

3-[(1-ethyl-1H-1,3-benzodiazol-2-yl)amino]propan-1-ol, 95.0%, 1g

Bis(2,5-dioxopyrrolidin-1-yl)-3,3'-(carbonylbis(azanediyl))dipropionate, 95.0%, 100mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-trans-(tert-butoxy)-L-proline>98.0%(HPLC)1g

2,6-Diazaspiro[3.4]octan-7-one, 98%, 1g

D-luciferin sodium salt, min 99%, for biochemistry, 10 mg, glass packaging

Xanthotoxin, min. 98%, 250 mg, glass packaging

2-FLUORO-1-(2-FLUORO-PHENYL)-ETHANONE, 95.0%, 2g

30 ml wide-neck glass glass brown GL 32 round

3,5-Bis(trifluoromethyl)benzeneboronic acid, 98.0%, 10g

Ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarboxylate, 95.0%, 5g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-1,2,3,4-tetrahydroisoquinoline, 98%, 1g